Median Technologies Is Releasing Full Year 2020 Financial Results (audited) as Well as Q1 2021 Business Activity Indicators, Showing a Very Strong Growth

Regulatory News:

Median Technologies (Paris:ALMDT) (Euronext Growth - ALMDT), whose Board of Directors met on April 6^th, 2021 to approve the consolidated financial statements for the financial year 2020, is today releasing its detailed audited full year financial results for 2020 as well as indicators on its business activity for the first quarter of 2021.

2020 results in line with expectations, reflecting the investments needed to accelerate growth and develop the iBiopsy platform

The company, which published indicators on January 14^th, 2021 on its 2020 business activity, confirms all the elements previously communicated. As of December 31^st, 2020:

- Annual revenue of €13.5m, up 51% on 2019 revenue (€9m), with constant quarterly growth,
- Cash and cash equivalents of €16.3m compared to €19.4m as of June 30^th, 2020,
- Order backlog¹ of €51.7m, an increase of 35% compared to backlog as of December 31^st, 2019 (€38.3m).

During the financial year 2020, the average number of employees in the Group was 125, with an acceleration of recruitment in the second half of the year. On December 31^st, 2020, the company had 141 employees.

Selected financial information (IFRS consolidated financial statements)

In thousands of euros (audited figures)	2020	2019
Revenue	13,478	8,951
Other income	113	80
Total revenue from ordinary activities	13,591	9,032
Staff costs	-11,718	-8,551
External costs	-9,468	- 7,436
Operating result	-8,819	- 7,963
Net financial result [*]	- 3,991	- 4
Net results	-12,802	- 7,984

[*] The net financial result should be understood as follows:

Interest on EIB loan